ProCure Treatment Centers
ProCure Treatment Centers develops and operates proton therapy centers in the United States, operating its flagship Somerset, New Jersey facility delivering Pencil Beam Scanning treatment for prostate, breast, brain, pediatric, and other cancers.
- Company typePrivate
- Founded2012
- HeadquartersNew York, United States
- Headcount251–500
- GTM typeB2C
- OfferingServices
What ProCure Treatment Centers does
ProCure Treatment Centers develops and operates a network of proton therapy centers in the United States. Founded in 2005 and headquartered in New York, the company operates its flagship facility in Somerset, New Jersey, which opened in March 2012 as the first proton therapy center in the tri-state area (New Jersey, New York, Connecticut). The Somerset facility has treated more than 8,000 patients since inception, including over 750 pediatric cases, and runs a care team of 251–500 employees across physicians, oncology nurses, support staff, and administrative personnel.
ProCure's core offering is proton therapy, an advanced form of radiation treatment that uses positively charged protons generated by a cyclotron instead of photons, allowing radiation to be deposited directly into the tumor and stop, thereby reducing exposure to surrounding healthy tissue. The Somerset facility is equipped with four specialized treatment rooms (two inclined-beam, one fixed-beam, and one 360-degree gantry), Pencil Beam Scanning (PBS), robotic patient positioning, real-time imaging, and the SpaceOAR Hydrogel spacer for prostate treatment. The center treats prostate, breast, brain, head and neck, lung, gastrointestinal, and pediatric cancers, with five-year cancer-free rates of 99% for early/intermediate prostate cancer and 76% for advanced prostate cancer, and up to 60% less radiation to the rectum, bladder, and bowel versus X-ray-based treatments.
ProCure generates revenue through professional services billed to Medicare, private insurers, and patients directly; treatment is covered by Medicare and many private insurance providers, with dedicated financial counselors supporting insurance navigation. The go-to-market combines physician referrals and clinical affiliations with major hospital systems (Hackensack Meridian Health, NYU Langone Health, Northwell Health, The Cancer Center at CentraState), a referral relationship with Memorial Sloan Kettering, and physician practice integration with Princeton Radiation Oncology. Demand generation is layered with event-driven patient education (Welcome Wednesdays/Tuesdays information sessions, specialty cancer awareness campaigns) and a content-marketing program of patient testimonials.
ProCure Treatment Centers firmographics
Firmographics- Name
- ProCure Treatment Centers
- Legal name
- ProCure Proton Therapy Center
- Website
- https://procure.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- ProCure Treatment Centers develops and operates proton therapy centers in the United States, operating its flagship Somerset, New Jersey facility delivering Pencil Beam Scanning treatment for prostate, breast, brain, pediatric, and other cancers.
- Ownership category
- akta.pro rank
ProCure Treatment Centers industry classification
Industry- Product category
- Radiation Oncology
- NAICS
- Offices of Physicians (62111), Diagnostic Imaging Centers (621512)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Radiation Oncology (HLAKAFAC)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB)
Keywords
Where ProCure Treatment Centers is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ProCure Treatment Centers business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Proton Therapy Treatment Services: ProCure generates revenue by providing proton therapy cancer treatment services to patients. Treatments are billed to insurance providers, Medicare, and patients directly. The center offers treatment for multiple cancer types including prostate, breast, brain, head and neck, lung, gastrointestinal, and pediatric cancers.
- Consultation and Information Services: Free information sessions are provided to educate potential patients about proton therapy. Paid consultations are scheduled for patients interested in pursuing treatment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Insurance-covered treatment |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
ProCure Treatment Centers product offering
Product offeringCore offering
ProCure Treatment Centers operates the ProCure Proton Therapy Center in Somerset, New Jersey, delivering proton radiation therapy to cancer patients as a direct medical service. The center offers Pencil Beam Scanning treatment across multiple cancer types, supported by a cyclotron, robotic patient positioning, real-time imaging, and SpaceOAR Hydrogel for rectal protection, and accepts patients through physician referrals, hospital partnerships, and direct inquiries.
Product overview
ProCure Proton Therapy Center offers a unified suite of cancer treatment services centered on proton therapy as its core offering. The center provides Pencil Beam Scanning proton therapy as its most advanced treatment option, complemented by SpaceOAR Hydrogel for rectal protection during prostate treatments. Patient-facing services include free Information Sessions, a Patient Portal for health information access, Online Bill Pay, and an Ambassador Program for peer support. The facility also offers facility tours and connects patients to clinical trials. Treatment is available for multiple cancer types including prostate, breast, brain, head and neck, lung, gastrointestinal, and pediatric cancers.
Differentiator
Problem solved
Functional benefit
Products and services
- Proton Therapy Advanced form of radiation treatment that destroys cancer cells by delivering radiation directly into the tumor and stopping, reducing exposure to surrounding healthy tissue. It is FDA-approved and used to treat prostate, breast, brain, head and neck, lung, gastrointestinal, and pediatric cancers.
- Free Information Sessions Free educational sessions at the ProCure Somerset facility where prospective patients can learn about proton therapy, meet the care team, and tour the facility.
- Patient Portal Online portal through ProCure's clinical partner Optimal Care for patients to access their health information and manage their care.
- Online Bill Pay Online payment service for patients to pay their proton therapy treatment bills through the ProCure website.
- Ambassador Program Peer support program where former ProCure patients share their experiences with new patients facing similar cancer journeys.
- Cyclotron Tour Guided tour of ProCure's cyclotron equipment used to generate proton beams for treatment, offered to patients and visitors.
Quantifiable outcome
- 99% cancer-free rate for early and intermediate prostate cancer at five years post-treatment
- +5 more outcomes
Companies that use ProCure Treatment Centers
Customer profileNamed customers5 records
Segments7 records
Ideal customer profiles3 records
ProCure Treatment Centers technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
ProCure Treatment Centers partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Hackensack Meridian HealthcoreClinical affiliation partnership where Hackensack Meridian Health refers patients to ProCure for proton therapy treatment. The partnership enables continued advancement of research and technology for proton therapy. Hackensack Meridian Health is one of the leading hospital systems in New Jersey with top cancer programs.
- NYU Langone HealthcoreClinical affiliation with NYU for proton therapy treatment referrals. NYU is a renowned academic medical center with leading cancer programs that collaborates with ProCure to bring proton therapy to patients.
- Northwell HealthcoreClinical affiliation with Northwell Health for proton therapy referrals. Northwell Health is one of the largest health systems in New York providing comprehensive cancer care and partners with ProCure to expand access to proton therapy.
- The Cancer Center at CentraStatecoreHospital partnership providing comprehensive cancer care beyond proton therapy. The Cancer Center at CentraState offers surgery, chemotherapy, hormone therapy, and immunity therapy, along with palliative care, survivorship programs, and post-treatment wellness resources. The partnership ensures patients receive comprehensive care before, during, and after proton therapy treatment.
- Princeton Radiation OncologycorePhysician practice partnership where radiation oncologists from Princeton Radiation Oncology treat patients at ProCure. Multiple physicians including Dr. Brian Chon, Dr. Henry Tsai, and Dr. Andrew Greenberg work with both ProCure and Princeton Radiation Oncology, enabling seamless patient care and treatment coordination.
- Memorial Sloan Kettering Cancer CenterminorReferral relationship where Memorial Sloan Kettering refers patients to ProCure for proton therapy when appropriate. Dr. Yu Yao, a radiation oncologist at Memorial Sloan Kettering, referred a nasopharyngeal cancer patient to ProCure for proton therapy treatment.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
ProCure Treatment Centers competitors and assessment
Company assessmentBroad incumbents
- Elekta: Major radiation therapy equipment manufacturer and solutions provider, including linear accelerators and stereotactic systems. Competes with proton therapy on the cost/benefit axis for conventional radiation oncology.
- Varian Medical Systems (Siemens Healthineers): Dominant radiation oncology equipment vendor (proton, photon, IMRT, CyberKnife) and increasingly an integrated cancer care operator. Not a direct clinical peer, but shapes the technology and competitive landscape ProCure operates within.
Direct peers
- Seattle Cancer Care Alliance Proton Therapy: Academic-affiliated proton therapy program treating comparable indications with Pencil Beam Scanning. Overlaps with ProCure in clinical capability and target patient population.
- Northwestern Medicine Chicago Proton Center: Regional proton therapy center serving the Midwest with cancer indications and technology comparable to ProCure. Geographic non-overlap but same patient mix and referral dynamics.
- Texas Center for Proton Therapy: Independently operated proton therapy center in the Dallas-Fort Worth area, treating prostate, breast, lung, and pediatric cancers. Comparable standalone model and competitive positioning within a regional market.
- Provision CARES Proton Therapy Center (Nashville): Independent, privately-financed proton therapy operator with multiple treatment rooms and a similar outpatient, multi-cancer treatment model. Directly comparable as a non-academic, single-market proton center.
- MD Anderson Proton Therapy Center: High-volume academic proton therapy program treating a similar multi-cancer population (prostate, breast, head/neck, lung, pediatric). Comparable technology stack and physician depth, though embedded in a larger hospital system.
- Massachusetts General Hospital Burr Proton Therapy Center: One of the original U.S. proton therapy centers, operating at Massachusetts General Hospital with similar Pencil Beam Scanning capability and a tertiary, multi-indication patient mix. Directly comparable clinical model and physician training pathway.
- Memorial Sloan Kettering Cancer Center Proton Therapy: Operates a multi-room proton facility in the NY metro area, directly competing with ProCure for tri-state patients and referral relationships. Already a referral source for ProCure for select cases.
- University of Florida Health Proton Therapy Institute: One of the largest standalone proton therapy centers in the U.S., treating a high volume of prostate, breast, lung, head/neck, and pediatric cancers. Closest analog to a multi-state proton therapy network operator.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
ProCure Treatment Centers social profiles
Digital presenceProCure Treatment Centers financial estimates
Financial estimateRevenue estimate
Valuation estimate
ProCure Treatment Centers leadership team
Management profileNumber of profiles
Profiles11 records
ProCure Treatment Centers funding detail
Funding detailFunding overview
Funding rounds5 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ProCure Treatment Centers M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ProCure Treatment Centers
What does ProCure Treatment Centers do?
ProCure Treatment Centers operates the ProCure Proton Therapy Center in Somerset, New Jersey, delivering proton radiation therapy to cancer patients as a direct medical service. The center offers Pencil Beam Scanning treatment across multiple cancer types, supported by a cyclotron, robotic patient positioning, real-time imaging, and SpaceOAR Hydrogel for rectal protection, and accepts patients through physician referrals, hospital partnerships, and direct inquiries.
Is ProCure Treatment Centers a public or private company?
ProCure Treatment Centers is a private company. It is classified as venture growth investor backed and is currently operating.
When was ProCure Treatment Centers founded?
ProCure Treatment Centers was founded in 2012. It employs 251 to 500 people.
Where is ProCure Treatment Centers based?
ProCure Treatment Centers is headquartered in New York, United States, in the North America region.
How does ProCure Treatment Centers make money?
Two revenue lines are on record. Proton Therapy Treatment Services are the primary driver. The others are consultation and Information Services.
Who are ProCure Treatment Centers's main competitors?
Broad incumbents on record are Elekta and Varian Medical Systems (Siemens Healthineers). Direct peers are Seattle Cancer Care Alliance Proton Therapy, Northwestern Medicine Chicago Proton Center, Texas Center for Proton Therapy, Provision CARES Proton Therapy Center (Nashville), MD Anderson Proton Therapy Center, Massachusetts General Hospital Burr Proton Therapy Center, Memorial Sloan Kettering Cancer Center Proton Therapy and University of Florida Health Proton Therapy Institute.
Does ProCure Treatment Centers have an API?
No public API is recorded for ProCure Treatment Centers.
What industry is ProCure Treatment Centers in?
ProCure Treatment Centers's product category is Radiation Oncology. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 62111 and its SIC code is 8011.